参考文献/References:
[1] Kirchhoff C.Molecular characterization of epididymal proteins[
J].Rev Reprod,1998,3(2):86-95.
[2] 陈 慧, 陈光辉, 梁映亮,等.联合检测血清HE4和CA153对乳腺癌早期诊断的价
值[J].国际检验医学杂志,2015,36(13):1893-1895.
Chen H,Chen GH,Liang YL,et al.The value of se-rum HE4 and CA153
in the early diagnosis of breast cancer[J].Int J Lab Med,2015,36(13):1893
-1895.
[3] Jiang YZ,Wang C,L BY,et al.Expression level of serum human
epididymis 4 and its prognostic significance in human non-small cell lung cance
r[J].Int J Clin Exp Med,2014,7(12):5568-5572.
[4] 邓拥军,郭秋霞.HE4,CA125,ROMA联合应用诊断卵巢良性与恶性肿瘤的作用[J]
.湖北中医药大学学报,2015,17(1):102-104.
Deng YJ,Guo QX. Effects of combined application of HE4,CA125 and
ROMA on diagnosis of ovarian benign and malignant Tumor[J].Journal of Hubei
University of Chinese Medicine,2015,17(1):102-104.
[5] Huang T,Jiang SW,Qin L,et al.Expression and diagnostic value of HE4
in pancreatic adenocarcinoma[J].Int J Mol Sci,2015,16(2):2956-2970.
[6] NKF-K/DOQI工作组慢性肾脏病及透析的临床实践指南(附述评)[M].王海燕,
王 梅,译.北京:人民卫生出版社,2003:7-8.
NKF-K/DOQI working groupClinical practice gui-delines of chronic
kidney disease and dialysis[M].Wang HY,Wang M,Translate.Beijing:People’
s Medical Publishing House,2003:7-8.
[7] 李 莉,刘凌云,赵元明.测定血清胱抑素C在肾脏疾病中的诊断价值[J].中华全科医学,2011,9(3):457-458.
Li L,Liu LY,Zhao YM,et al.Value of detecting se-rum Cystatin Cin diagnosis of kidney disease[J].Chinese Journal of General Practice,2011,9(3):457-458.
[8] Li JP,Dowdy S,Tipton T,et al.HE4 as a biomarker for ovarian and endometrial cancer management[J].Expert Rev Mol Diagn,2009,9(6):555-566.
[9] 石少凤,田德明,黄文斌,等.人附睾分泌蛋白4在卵巢上皮性肿瘤中的表达及其临床意义[J].皖南医学院学报,2014,33(5):402-404,408.
Shi SF,Tian DM,Huang WB,et al.Expression of human epididymis protein 4 in ovarian epithelial tumors and its clinical significance[J].Journalof Wannan Medical College,2014,33(5):402-404,408.
[10] Chen Y,Chen Q,Liu Q,et al.Human epididymis protein 4 expression positively correlated with miR-21 and served as a prognostic indicator in ovarian cancer[J].Tumour Biol,2016,37(6):8359-8365.
[11] 闫先侠,孙 晓,张 华,等.血清人附睾蛋白4联合CA125检测在卵巢癌诊断中的应用[J].现代检验医学杂志,2015,30(1):134-136.
Yan XX,Sun X,Zhang H,et al.Combined detection serum human epididym protein 4 with carbohydrate antigen 125 and its implication in the diagnosis of ovarian cancer[J].Journal of Modern Laboratory Medicine,2015,30(1):134-136.
[12] Escudero JM,Auge JM,Filella X,et al.Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases[J].Clin Chem,2011,57(11):1534-1544.
[13] Nagy B,Krasznai ZT,Balla H,et al.Elevated human epididymis protein 4concentrations in chronic kidney disease[J].Ann Clin Biochem,2012,49(Pt 4):377-380.
相似文献/References:
[1]王洁敏,向 芃,顾乐怡.不同预处理方法对提取尿液脱落细胞mRNA质量的影响[J].现代检验医学杂志,2016,31(04):125.[doi:10.3969/j.issn.1671-7414.2016.04.035]
WANG Jie-min,XIANG Peng,GU Le-yi.Effects of Different Pretreatment Methods on mRNA Quality
and Quantity of Exfoliated Urinary Cells[J].Journal of Modern Laboratory Medicine,2016,31(02):125.[doi:10.3969/j.issn.1671-7414.2016.04.035]
[2]肖传宇,王 宁,王小艳,等.血清胰岛素与慢性肾脏病的相关研究及其应用价值[J].现代检验医学杂志,2017,32(01):109.[doi:10.3969/j.issn.1671-7414.2017.01.030]
XIAO Chuan-yu,WANG Ni,WANG Xiao-yan,et al.Correlation of Serum Insulin and Chronic Kidney Disease
and Its Application Value[J].Journal of Modern Laboratory Medicine,2017,32(02):109.[doi:10.3969/j.issn.1671-7414.2017.01.030]
[3]杨 雄,尹爱萍.慢性肾脏病不同分期患者血清多项骨代谢指标变化与成纤维细胞生长因子23的相关性分析[J].现代检验医学杂志,2019,34(04):58.[doi:10.3969/j.issn.1671-7414.2019.04.014]
YANG Xiong.,YIN Ai-ping.Analysis of the Correlation between Serum Bone Metabolism
and Fibroblast Growth Factor 23 in Patients
with Chronic Kidney Disease at Different Stages[J].Journal of Modern Laboratory Medicine,2019,34(02):58.[doi:10.3969/j.issn.1671-7414.2019.04.014]
[4]杨 雄,尹爱萍.慢性肾脏病患者血液中FGF23,TNF-α,RANTES 和IL-12 检测水平的相关性研究[J].现代检验医学杂志,2020,35(01):25.[doi:10.3969/j.issn.1671-7414.2020.01.007]
YANG Xiong,YIN Ai-ping.Correlation between FGF23,TNF-α, RANTES and IL-12 Levels
in the Bloodof Patients with Chronic Kidney Disease[J].Journal of Modern Laboratory Medicine,2020,35(02):25.[doi:10.3969/j.issn.1671-7414.2020.01.007]
[5]曹 雷a,汪隆海a,周 梅a,等.慢性肾心综合征患者血清9项心衰标志物水平联合检测的实验诊断价值研究[J].现代检验医学杂志,2021,36(05):90.[doi:10.3969/j.issn.1671-7414.2021.05.020]
CAO Leia,WANG Long-haia,ZHOU Meia,et al.Study on Experimental Diagnostic Value for Combined Detection of 9 HeartFailure Markers in Serum of Patients with Chronic Renal Heart Syndrome[J].Journal of Modern Laboratory Medicine,2021,36(02):90.[doi:10.3969/j.issn.1671-7414.2021.05.020]
[6]王若霜,冷彦飞,袁飞远.mitoTEMPO 通过调控线粒体自噬对慢性肾脏病模型大鼠足细胞损伤的保护作用研究[J].现代检验医学杂志,2024,39(05):22.[doi:10.3969/j.issn.1671-7414.2024.05.005]
WANG Ruoshuang,LENG Yanfei,YUAN Feiyuan.Study on the Protective Effect of mitoTEMPO on Podocyte Injury in Rat Models with Chronic Kidney Disease by Modulating Mitochondrial Autophagy[J].Journal of Modern Laboratory Medicine,2024,39(02):22.[doi:10.3969/j.issn.1671-7414.2024.05.005]
[7]贾红红,李红莉,孙丽华.慢性肾脏病患者血清BMP2,BMP7水平表达与左心室肥厚的相关性研究[J].现代检验医学杂志,2024,39(06):179.[doi:10.3969/j.issn.1671-7414.2024.06.031]
JIA Honghong,LI Hongli,SUN Lihua.Study on Association between Serum BMP2, BMP7 Level and Left Ventricular Hypertrophy among Chronic Kidney Disease Patients[J].Journal of Modern Laboratory Medicine,2024,39(02):179.[doi:10.3969/j.issn.1671-7414.2024.06.031]